CAR T-cell therapy
![CAR T-cell therapy, blood cancer treatment, immunotherapy, personalized targeting, breakthrough, benefits, risks, approved therapies, leukemia, lymphoma, multiple myeloma,](https://pharmtales.com/wp-content/uploads/2023/08/CAR-T-Cell-Therapy-in-Hematological-Malignancies.jpg)
CAR T-Cell Therapy in Hematological Malignancies: A Breakthrough or a Bust?
Anika Sharma
Hematological malignancies are cancers that affect the blood, bone marrow, and lymph nodes. They include leukemia, lymphoma, and multiple myeloma. ...
![How BCMA-targeted therapies are changing the game for multiple myeloma](https://pharmtales.com/wp-content/uploads/2023/07/How-BCMA-targeted-therapies-are-changing-the-game-for-multiple-myeloma.jpg)
How BCMA-targeted therapies are changing the game for multiple myeloma
SG Tylor
Imagine a world where you could treat cancer with a simple injection or infusion, without the need for surgery, chemotherapy, ...